Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quality of response to bortezomib + dexamethasone in previously untreated multiple myeloma
2008-003936-38Phase 4Completed
- Sponsor
- Taysha Gene Therapies
- Start
- Jul 2008
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bortezomib in multiple myeloma (MM), sponsored by Taysha Gene Therapies. Primary endpoint: Quality and depth of treatment response. Started Jul 2008; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2008-003936-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003936-38.